Skip to main content

ScanSource to Announce First Quarter Fiscal Year 2022 Results November 9, 2021

ScanSource, Inc. (NASDAQ: SCSC), a leading provider of technology products and solutions, announced today that it plans to release first quarter fiscal year 2022 results for the period ended September 30, 2021 on Tuesday, November 9, 2021 at approximately 4:00 p.m. ET. ScanSource management will host an earnings conference call to discuss these results later that day, November 9, 2021, at 5:00 p.m. ET.

The earnings conference call may be accessed via a live Internet webcast in the Investor Relations section of ScanSource, Inc.’s web site, www.scansource.com. A replay of the webcast will be available at www.scansource.com for 60 days.

About ScanSource, Inc.

ScanSource, Inc. (NASDAQ: SCSC) is at the center of the technology solution delivery channel, connecting businesses and providing solutions for their complex needs. ScanSource sells through multiple, specialized routes-to-market with digital, physical and services offerings from the world’s leading suppliers of point-of-sale (POS), payments, barcode, physical security, unified communications and collaboration, telecom and cloud services. ScanSource enables its sales partners to create, deliver and manage solutions for end-customers across almost every vertical market. Founded in 1992 and headquartered in Greenville, South Carolina, ScanSource was named one of the 2021 Best Places to Work in South Carolina and on FORTUNE magazine’s 2021 List of World’s Most Admired Companies. ScanSource ranks #655 on the Fortune 1000. For more information, visit www.scansource.com.

Contacts:

Mary Gentry, ScanSource, Inc.
SVP, Treasurer and Investor Relations
864.286.4892
mary.gentry@scansource.com

Steve Jones, ScanSource, Inc.
Chief Financial Officer
864.286.4302
steve.jones@scansource.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.